ANGELINI PHARMA
LIVE

Serial Number

50028191

Owner

Angelini Pharma S.p.A.

Attorney

Peter A. Chiabotti

Filing Date

Aug 3, 2026

Add to watchlist:

No watchlists yet
View on USPTO

ANGELINI PHARMA Trademark

Serial Number: 50028191

ANGELINI PHARMA is a trademark filed by Angelini Pharma S.p.A. on August 3, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Angelini Pharma S.p.A. (8 trademarks)

Viale Amelia, 70

Entity Type: 09

Trademark Details

Filing Date

August 3, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Antipyretic analgesics; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Dietary and nutritional supplements; Nutraceuticals for use as a dietary supplement; Natural herbal supplements; Herbal supplements; Food supplements; Dietary food supplements; Transdermal patches featuring analgesic medication for topical pain relief; Transdermal patches for use in the treatment of muscle and joint pain; Disinfectants; All purpose disinfectants; Disinfectants for hygienic purposes; Disinfectants for sanitary purposes; Disinfectants for hygiene purposes; Vitamin and mineral supplements; Vitamins; Mineral supplements; Multivitamin preparations; Mineral nutritional supplements; Pharmaceutical preparations for the treatment of rare neurological diseases; pharmaceutical preparations for the treatment of autoimmune, neuromuscular and neurological diseases

Filing History

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Aug 3, 2026 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 3, 2026 PARI
APPLICATION FILING RECEIPT MAILED
Aug 3, 2026 MAFR
NEW APPLICATION ENTERED
Aug 3, 2026 NWAP